[MicroRNA and obesity. A modern view of the problem (review of literature).]

МикроРНК и ожирение. Современный взгляд на проблему (обзор литературы).

Journal

Klinicheskaia laboratornaia diagnostika
ISSN: 0869-2084
Titre abrégé: Klin Lab Diagn
Pays: Russia (Federation)
ID NLM: 9432021

Informations de publication

Date de publication:
04 Jun 2020
Historique:
entrez: 8 8 2020
pubmed: 8 8 2020
medline: 3 11 2020
Statut: ppublish

Résumé

The incidence of obesity is steadily increasing worldwide, reaching the epidemic. Obesity is associated with cardiometabolic diseases through the complex interactions between genetics and epigenetics predisposition, the environment, diet, and lifestyle. However, the molecular mechanisms and factors influencing these processes are not fully known. MicroRNAs are a new class of important regulatory determinants in many biological and pathological processes. There is increasing evidence of the role of miRNAs in the regulation of the functional activity of adipose tissue and the development of obesity. A change in the expression of MicroRNAs can lead to changes in the activity of genes that control a number of biological processes, including inflammation, lipid metabolism, and adipogenesis. Understanding the role of miRNAs in the regulation of adipogenesis and the development of obesity will establish therapeutic targets for the development of new and effective drugs, which will lead to a breakthrough in the fight against obesity and related diseases. This review presents current data on the role of miRNAs in the regulation of the functional activity of adipose tissue, including adipogenesis of white, beige and brown adipocytes, as well as the prerequisites for using miRNAs as biomarkers of obesity and the possibility of therapeutic use.

Identifiants

pubmed: 32762178
doi: 10.18821/0869-2084-2020-65-7-411-417
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Review

Langues

rus

Sous-ensembles de citation

IM

Pagination

411-417

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Taubes G. The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes. BMJ. 2013;346:f1050. doi: 10.1136/bmj.f1050
Gruzdeva O., Borodkina D., Uchasova E., Dyleva Y., Barbarash O. Localization of fat depots and cardiovascular risk 11 medical and health sciences 1103 clinical sciences. Lipids in Health and Disease. 2018; 17 (1): 218. doi: 10.1186/s12944-018-0856-8
Gruzdeva O.V., Akbasheva O.E., Borodkina D.A., Karetnikova V.N., Dyleva Y., Kokov A.N. Relationship of obesity parameters and adipokines with the risk of 2nd type diabetes development in a year after myocardial infarction. Rossiyskiy kardiologicheskiy zhurnal. 2015;(4): 59-67. doi: 10.15829/1560-4071-2015-4-59-67 (in Russian)
Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131:242e56. doi: 10.1016/j.cell.2007.10.004
Vienberg S., Geiger J., Madsen S., Dalgaard L.T. MicroRNAs in metabolism. Acta Physiol. (Oxf). 2017;219:346e61. doi: 10.1111/apha.12681
Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 2008;9:102-14. doi: 10.1038/nrg2290
Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell. 2010;38:323-32. doi: 10.1016/j.molcel.2010.03.013
Rand T.A., Ginalski K., Grishin N.V., Wang X. Biochemical identification of Argonaute 2 as the sole protein required for RNAinduced silencing complex activity. Proc. Natl. Acad. Sci. USA. 2004;101:14385-9. doi: 10.1038/nature08170
Karbiener M., Fischer C., Nowitsch S., Opriessnig P., Papak C., Ailhaud G. et al. MicroRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem. Biophys. Res. Commun. 2009;390:247e51. doi: 10.1016/j.bbrc.2009.09.098
Kraus M., Greither T., Wenzel C., Bräuer-Hartmann D., Wabitsch M., Behre H.M. Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgenregulated microRNA miR-375. Mol. Cell. Endocrinol. 2015;414:177e85. doi: 10.1016/j.mce.2015.07.026
Li H., Li T., Wang S., Wei J., Fan J., Li J. et al. MiR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem. Cell Res. 2013;10: 313e24. doi: 10.1016/j.scr.2012.11.007
Li M., Liu Z., Zhang Z., Liu G., Sun S., Sun C. miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D. Biol. Chem. 2015;396:235e44. doi: 10.1515/hsz-2014-0241
Peng Y., Li H., Li X., Yu S., Xiang H., Penget J. et al. MicroRNA-215 impairs adipocyte differentiation and co-represses FNDC3B and CTNNBIP1. Int. J. Biochem. Cell. Biol. 2016. 79:104-12. doi: 10.1016/j.biocel.2016.08.014
Giordano A., Frontini A., Cinti S. Convertible visceral fat as a therapeutic target to curb obesity. Nat. Rev. Drug. Discov. 2016;15:405e24. doi: 10.1038/nrd.2016.31
Karbiener M., Pisani D.F., Frontini A., Oberreiter L.M., Lang E., Vegiopoulos A. et al. MicroRNA-26 family is required for human adipogenesis and drives characteristics of brown adipocytes. Stem. Cells. 2014;32:1578e90. doi: 10.1002/stem.1603
Feuermann Y., Kang K., Gavrilova O., Haetscher N., Jang S.J., Yooet K.H. et al. MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse. RNA Biol. 2013;10:1807e14. doi: 10.4161/rna.27239
Wu Y., Zuo J., Zhang Y., Xie Y., Hu F., Chenet L. et al. Identification of miR-106b-93 as a negative regulator of brown adipocyte differentiation. Biochem. Biophys. Res. Commun. 2013;438: 575e80. doi: 10.1016/j.bbrc.2013.08.016
Meakin P.J., Harper A.J., Hamilton D.L., Gallagher J., McNeilly A.D., Burgess L.A. et al. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem. J. 2012;441:285e96. doi: 10.1042/BJ20110512
Chou C-F, Lin Y-Y, Wang H-K., Zhu X., Giovarelli M., Briata P. et al. KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression. Diabetes. 2014;63:2949e61. doi: 10.2337/db13-1901
Sun L., Trajkovski M. MiR-27 orchestrates the transcriptional regulation of brown adipogenesis. Metab. Clin. Exp. 2014;63: 272e82. doi: 10.1016/j.metabol.2013.10.004
Hall A.M., Kou K., Chen Z., Pietka T.A., Kumar M., Korenblatet K.M. et al. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. J. Lipid. Res. 2012;53:990-999. doi: 10.1194/jlr.P025536
Reis F.C., Branquinho J.L., Brandao B.B., Guerra B.A., Silva I.D., Frontini A. et al. Fat-specific Dicer deficiency accelerates aging and mitigates several effects of dietary restriction in mice. Aging (Albany NY). 2016;8:1201-22.
Ortega F.J., Moreno-Navarrete J.M., Pardo G., Sabater M., Hummel M., Ferrer A. et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One. 2010;5(2):e9022. doi: 10.1371/journal.pone.0009022
Kristensen M.M., Davidsen P.K., Vigelsо A., Hansen C.N., Jensen L.J., Jessen N.et al. miRNAs in human subcutaneous adipose tissue: effects of weight loss induced by hypocaloric diet and exercise. Obes. (Silver Spring). 2017; 25(3):572-80. doi: 10.1002/oby.21765
Meerson A., Traurig M., Ossowski V., Fleming J.M., Mullins M., Baier L.J. Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-a. Diabetologia. 2013;56:1971e9. doi: 10.1007/s00125-013-2950-9
Wang J., Guan X., Guo F., Zhou J., Chang A., Sun B. et al. miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis. 2013;4:e845. doi: 10.1038/cddis.2013.356
Martinelli R., Nardelli C., Pilone V., Buonomo T., Liguori R., Castanò I., et al. miR-519d overexpression is associated with human obesity. Obesity. 2010;18:2170e6. doi: 10.1038/oby.2009.474
Kornfeld J.W., Baitzel C., Könner A.C., Nicholls H.T., Vogt M.C., Herrmanns K., et al. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature. 2013;494:111e5. doi: 10.1038/nature11793
Mysore R., Zhou Y., Sädevirta S., Savolainen-Peltonen H., Haridas P.A.N., Soronen J. et al. MicroRNA-192 impairs adipocyte triglyceride storage. Biochim. Biophys. Acta. 2016;1861:342-51. doi: 10.1016/j.bbalip.2015.12.019
Parra P., Serra F., Palou A. Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One. 2010;5:e13005. doi: 10.1371/journal.pone.0013005
Ortega F.J., Mercader J.M., Moreno-Navarrete J.M., Rovira O., Guerra E., Esteve E. et al. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014;37:1375-83. doi: 10.2337/dc13-1847
Villard A., Marchand L., Thivolet C., Rome S. Diagnostic value of cell-free circulating microRNAs for obesity and type 2 diabetes: a meta-analysis. J. Mol. Biomark. Diagn. 2015;6(6):251. doi: 10.4172/2155-9929.1000251
Carreras-Badosa G., Bonmatí A., Ortega F.J., Mercader J.-M., Guindo-Martínez M., Torrents D. et al. Altered circulating miRNA expression profile in pregestational and gestational obesity. J. Clin. Endocrinol. Metab. 2015;100:E1446-56. doi: 10.1210/jc.2015-2872
Iacomino G., Russo P., Stillitano I., Lauria F., Marena P., Ahrens W. et al. Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I.Family study. Genes Nutr. 2016;11:7. doi: 10.1186/s12263-016-0525-3
Masotti A., Baldassarre A., Fabrizi M. Olivero G., Loreti M.C., Giammariaet P. et al. Oral glucose tolerance test unravels circulating miRNAs associated with insulin resistance in obese preschoolers. Pediatr. Obes. 2016;2(3):229-38. doi: 10.1111/ijpo.12133
Can U., Buyukinan M., Yerlikaya F.H. The investigation of circulating microRNAs associated with lipid metabolism in childhood obesity. Pediatr. Obes. 2016;11:228-34. doi: 10.1111/ijpo.12050
Gaudet A.D., Fonken L.K., Gushchina L.V., Aubrecht T.G., Maurya S.K., Periasamy M. et al. miR-155 deletion in female mice prevents diet-induced obesity. Sci. Rep. 2016;6: 22862. doi: 10.1038/srep22862
Price N.L., Holtrup B., Kwei S.L., Wabitsch M., Rodeheffer M., Bianchini L.et al. SREBP-1c/MicroRNA 33b genomic loci control adipocyte differentiation. Mol. Cell Biol. 2016;36:1180-93. doi: 10.1128/MCB.00745-15
Huang-Doran I., Zhang C.Y., Vidal-Puig A. Extracellular vesicles: novel mediators of cell communication in metabolic disease. Trends Endocrinol. Metab. 2017;28:3-18. doi: 10.1016/j.tem.2016.10.003
Heneghan H.M., Miller N., McAnena O.J., O’Brien T., Kerinet M.J. et al. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J. Clin. Endocrinol. Metab. 2011;96:E846-50. doi: 10.1210/jc.2010-2701
Ameling S., Kacprowski T., Chilukoti R.K., Malsch C., Liebscher V., Suhre K. et al. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC Med. Genomics. 2015;8:61. doi: 10.1186/s12920-015-0136-7
Chen Y., Buyel J.J., Hanssen M.J. 2016b. Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat. Commun. 2016;7:11420. doi: 10.1038/ncomms11420

Auteurs

Yu A Dyleva (YA)

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, 650002, Kemerovo, Russian Federation.

O V Gruzdeva (OV)

Federal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, 650002, Kemerovo, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH